跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Cifloxone - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Cifloxone
Approved
STANDARD
Cifloxone
Swiss Parenterals Ltd. (Block-B)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b47df2fa1e9f6afb
Company
Swiss Parenterals Ltd. (Block-B)
Type
Standard
Approval Details
Approval Id
b47df2fa1e9f6afb
Drug Approval Philippines Name
Cifloxone
Product Name
Cifloxone
Registration Number
DRP-16469
Brand Name
Cifloxone
Generic Name
Ciprofloxacin (as hydrochloride) + Dexamethasone (as sodium phosphate)
Dosage Form
Ophthalmic Drops
Dosage Strength
3 mg/1 mg per mL (0.3% w/v per 0.1% w/v)
Manufacturer
Swiss Parenterals Ltd. (Block-B)
Importer
Despina Pharma Inc.
Distributor
Despina Pharma Inc.
Issuance Date
28 April 2025
Expiry Date
28 April 2030
Pharmacologic Category
Corticosteroid combination with antibiotic
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b47df2fa1e9f6afb
Type
Standard
Back to Philippines FDA Approvals